What is City Therapeutics worth?
$285.5Mlast known valuation
City Therapeutics last raised $135.0M in its Early Stage VC (Series A) (Oct 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for City Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2024 | Early Stage VC (Series A) | $135.0M | ▮ | ▮ |
How City Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For City Therapeutics, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is City Therapeutics worth?
- City Therapeutics's implied valuation is $285.5M, based on the PA Mark composite price of about $15 per share as of Sep 2026.
- How much has City Therapeutics raised?
- City Therapeutics has raised $139.5M in total funding across 1 recorded rounds.
- When did City Therapeutics last raise?
- City Therapeutics last raised in Oct 2024 (Early Stage VC (Series A)), raising $135.0M.